Surgical Aortic Valve Replacement to Treat Prosthetic Valve Endocarditis After Valve-in-Valve Transcatheter Aortic Valve Replacement
Prosthetic valve endocarditis (PVE) is an uncommon complication after heart valve replacement surgery that can result in increased morbidity and mortality. Current guidelines for management of PVE recommend antibiotic therapy followed by surgical valve replacement. The number of aortic valve replace...
Gespeichert in:
| Veröffentlicht in: | Curēus (Palo Alto, CA) CA), 2023-04, Vol.15 (4), p.e38021 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 4 |
| container_start_page | e38021 |
| container_title | Curēus (Palo Alto, CA) |
| container_volume | 15 |
| creator | Jena, Nihar Patel, Kinjal Desai, Ronak Siddiqui, Nazia Ahluwalia, Guneet Halabi, Abdul R Schwartz, Charles Krishnan, Sandeep |
| description | Prosthetic valve endocarditis (PVE) is an uncommon complication after heart valve replacement surgery that can result in increased morbidity and mortality. Current guidelines for management of PVE recommend antibiotic therapy followed by surgical valve replacement. The number of aortic valve replacements is expected to rise in the coming years with the expanded indications for use of transcatheter aortic valve replacement (TAVR) in patients with low, intermediate, and high surgical risk, as well as in patients with a failed aortic bioprosthetic valve. Current guidelines do not address the use of valve-in-valve (ViV) TAVR for management of PVE in patients who are at high risk for surgical intervention. The authors present a case of a patient with aortic valve PVE after surgical aortic valve replacement (SAVR); he was treated with valve-in-valve (ViV) TAVR due to the high surgical risk. The patient was discharged, but he returned to the hospital with PVE and valve dehiscence 14 months after ViV TAVR, after which he successfully underwent re-operative SAVR. |
| doi_str_mv | 10.7759/cureus.38021 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10205151</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2821273405</sourcerecordid><originalsourceid>FETCH-LOGICAL-c267t-b5acbcfb3f4ccd7771da9f7cb69731b2bd1aa3f724124a4e56207c825590303c3</originalsourceid><addsrcrecordid>eNp1kc1PwjAYxhujEYLcPJslXh32Y13HyRCCHwmJRtFr03UdlIwV247Eu3-4xSHiwVObPL8-z_v2AeAcwQFjdHgtG6saNyAZxOgIdDFKszhDWXJ8cO-AvnNLCCGCDEMGT0GHMIwzmqRd8PnS2LmWoopGxnotozdRbVT0rNaVkGqlah95E82sEj56ssb5hfqlJnVhpLCF9tpFo9Ir2wqxruOWmFlROym2r4L4X8QZOClF5VR_d_bA6-1kNr6Pp493D-PRNJY4ZT7OqZC5LHNSJlIWjDFUiGHJZJ4OGUE5zgskBCkZThBORKJoGtaVGaZ0CAkkkvTATeu7bvKVKmSItqLia6tXwn5wIzT_q9R6wedmwxHEkCKKgsPlzsGa90Y5z5emsXUYmuMMI8xIAmmgrlpKhh9zVpX7CAT5tjfe9sa_ewv4xeFYe_inJfIFocOXvw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2821273405</pqid></control><display><type>article</type><title>Surgical Aortic Valve Replacement to Treat Prosthetic Valve Endocarditis After Valve-in-Valve Transcatheter Aortic Valve Replacement</title><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>Jena, Nihar ; Patel, Kinjal ; Desai, Ronak ; Siddiqui, Nazia ; Ahluwalia, Guneet ; Halabi, Abdul R ; Schwartz, Charles ; Krishnan, Sandeep</creator><creatorcontrib>Jena, Nihar ; Patel, Kinjal ; Desai, Ronak ; Siddiqui, Nazia ; Ahluwalia, Guneet ; Halabi, Abdul R ; Schwartz, Charles ; Krishnan, Sandeep</creatorcontrib><description>Prosthetic valve endocarditis (PVE) is an uncommon complication after heart valve replacement surgery that can result in increased morbidity and mortality. Current guidelines for management of PVE recommend antibiotic therapy followed by surgical valve replacement. The number of aortic valve replacements is expected to rise in the coming years with the expanded indications for use of transcatheter aortic valve replacement (TAVR) in patients with low, intermediate, and high surgical risk, as well as in patients with a failed aortic bioprosthetic valve. Current guidelines do not address the use of valve-in-valve (ViV) TAVR for management of PVE in patients who are at high risk for surgical intervention. The authors present a case of a patient with aortic valve PVE after surgical aortic valve replacement (SAVR); he was treated with valve-in-valve (ViV) TAVR due to the high surgical risk. The patient was discharged, but he returned to the hospital with PVE and valve dehiscence 14 months after ViV TAVR, after which he successfully underwent re-operative SAVR.</description><identifier>ISSN: 2168-8184</identifier><identifier>EISSN: 2168-8184</identifier><identifier>DOI: 10.7759/cureus.38021</identifier><identifier>PMID: 37228546</identifier><language>eng</language><publisher>United States: Cureus Inc</publisher><subject>Anesthesiology ; Antibiotics ; Blood pressure ; Cardiac/Thoracic/Vascular Surgery ; Cardiology ; Edema ; Endocarditis ; Esophagus ; Fistula ; Heart failure ; Hypertension ; Kidney diseases ; Leukocytes ; Patients ; Prostheses ; Pulmonary embolisms ; Surgery ; Tomography ; Ultrasonic imaging</subject><ispartof>Curēus (Palo Alto, CA), 2023-04, Vol.15 (4), p.e38021</ispartof><rights>Copyright © 2023, Jena et al.</rights><rights>Copyright © 2023, Jena et al. This work is published under https://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright © 2023, Jena et al. 2023 Jena et al.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c267t-b5acbcfb3f4ccd7771da9f7cb69731b2bd1aa3f724124a4e56207c825590303c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10205151/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10205151/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37228546$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jena, Nihar</creatorcontrib><creatorcontrib>Patel, Kinjal</creatorcontrib><creatorcontrib>Desai, Ronak</creatorcontrib><creatorcontrib>Siddiqui, Nazia</creatorcontrib><creatorcontrib>Ahluwalia, Guneet</creatorcontrib><creatorcontrib>Halabi, Abdul R</creatorcontrib><creatorcontrib>Schwartz, Charles</creatorcontrib><creatorcontrib>Krishnan, Sandeep</creatorcontrib><title>Surgical Aortic Valve Replacement to Treat Prosthetic Valve Endocarditis After Valve-in-Valve Transcatheter Aortic Valve Replacement</title><title>Curēus (Palo Alto, CA)</title><addtitle>Cureus</addtitle><description>Prosthetic valve endocarditis (PVE) is an uncommon complication after heart valve replacement surgery that can result in increased morbidity and mortality. Current guidelines for management of PVE recommend antibiotic therapy followed by surgical valve replacement. The number of aortic valve replacements is expected to rise in the coming years with the expanded indications for use of transcatheter aortic valve replacement (TAVR) in patients with low, intermediate, and high surgical risk, as well as in patients with a failed aortic bioprosthetic valve. Current guidelines do not address the use of valve-in-valve (ViV) TAVR for management of PVE in patients who are at high risk for surgical intervention. The authors present a case of a patient with aortic valve PVE after surgical aortic valve replacement (SAVR); he was treated with valve-in-valve (ViV) TAVR due to the high surgical risk. The patient was discharged, but he returned to the hospital with PVE and valve dehiscence 14 months after ViV TAVR, after which he successfully underwent re-operative SAVR.</description><subject>Anesthesiology</subject><subject>Antibiotics</subject><subject>Blood pressure</subject><subject>Cardiac/Thoracic/Vascular Surgery</subject><subject>Cardiology</subject><subject>Edema</subject><subject>Endocarditis</subject><subject>Esophagus</subject><subject>Fistula</subject><subject>Heart failure</subject><subject>Hypertension</subject><subject>Kidney diseases</subject><subject>Leukocytes</subject><subject>Patients</subject><subject>Prostheses</subject><subject>Pulmonary embolisms</subject><subject>Surgery</subject><subject>Tomography</subject><subject>Ultrasonic imaging</subject><issn>2168-8184</issn><issn>2168-8184</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNp1kc1PwjAYxhujEYLcPJslXh32Y13HyRCCHwmJRtFr03UdlIwV247Eu3-4xSHiwVObPL8-z_v2AeAcwQFjdHgtG6saNyAZxOgIdDFKszhDWXJ8cO-AvnNLCCGCDEMGT0GHMIwzmqRd8PnS2LmWoopGxnotozdRbVT0rNaVkGqlah95E82sEj56ssb5hfqlJnVhpLCF9tpFo9Ir2wqxruOWmFlROym2r4L4X8QZOClF5VR_d_bA6-1kNr6Pp493D-PRNJY4ZT7OqZC5LHNSJlIWjDFUiGHJZJ4OGUE5zgskBCkZThBORKJoGtaVGaZ0CAkkkvTATeu7bvKVKmSItqLia6tXwn5wIzT_q9R6wedmwxHEkCKKgsPlzsGa90Y5z5emsXUYmuMMI8xIAmmgrlpKhh9zVpX7CAT5tjfe9sa_ewv4xeFYe_inJfIFocOXvw</recordid><startdate>20230423</startdate><enddate>20230423</enddate><creator>Jena, Nihar</creator><creator>Patel, Kinjal</creator><creator>Desai, Ronak</creator><creator>Siddiqui, Nazia</creator><creator>Ahluwalia, Guneet</creator><creator>Halabi, Abdul R</creator><creator>Schwartz, Charles</creator><creator>Krishnan, Sandeep</creator><general>Cureus Inc</general><general>Cureus</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope></search><sort><creationdate>20230423</creationdate><title>Surgical Aortic Valve Replacement to Treat Prosthetic Valve Endocarditis After Valve-in-Valve Transcatheter Aortic Valve Replacement</title><author>Jena, Nihar ; Patel, Kinjal ; Desai, Ronak ; Siddiqui, Nazia ; Ahluwalia, Guneet ; Halabi, Abdul R ; Schwartz, Charles ; Krishnan, Sandeep</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c267t-b5acbcfb3f4ccd7771da9f7cb69731b2bd1aa3f724124a4e56207c825590303c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Anesthesiology</topic><topic>Antibiotics</topic><topic>Blood pressure</topic><topic>Cardiac/Thoracic/Vascular Surgery</topic><topic>Cardiology</topic><topic>Edema</topic><topic>Endocarditis</topic><topic>Esophagus</topic><topic>Fistula</topic><topic>Heart failure</topic><topic>Hypertension</topic><topic>Kidney diseases</topic><topic>Leukocytes</topic><topic>Patients</topic><topic>Prostheses</topic><topic>Pulmonary embolisms</topic><topic>Surgery</topic><topic>Tomography</topic><topic>Ultrasonic imaging</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jena, Nihar</creatorcontrib><creatorcontrib>Patel, Kinjal</creatorcontrib><creatorcontrib>Desai, Ronak</creatorcontrib><creatorcontrib>Siddiqui, Nazia</creatorcontrib><creatorcontrib>Ahluwalia, Guneet</creatorcontrib><creatorcontrib>Halabi, Abdul R</creatorcontrib><creatorcontrib>Schwartz, Charles</creatorcontrib><creatorcontrib>Krishnan, Sandeep</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Curēus (Palo Alto, CA)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jena, Nihar</au><au>Patel, Kinjal</au><au>Desai, Ronak</au><au>Siddiqui, Nazia</au><au>Ahluwalia, Guneet</au><au>Halabi, Abdul R</au><au>Schwartz, Charles</au><au>Krishnan, Sandeep</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Surgical Aortic Valve Replacement to Treat Prosthetic Valve Endocarditis After Valve-in-Valve Transcatheter Aortic Valve Replacement</atitle><jtitle>Curēus (Palo Alto, CA)</jtitle><addtitle>Cureus</addtitle><date>2023-04-23</date><risdate>2023</risdate><volume>15</volume><issue>4</issue><spage>e38021</spage><pages>e38021-</pages><issn>2168-8184</issn><eissn>2168-8184</eissn><abstract>Prosthetic valve endocarditis (PVE) is an uncommon complication after heart valve replacement surgery that can result in increased morbidity and mortality. Current guidelines for management of PVE recommend antibiotic therapy followed by surgical valve replacement. The number of aortic valve replacements is expected to rise in the coming years with the expanded indications for use of transcatheter aortic valve replacement (TAVR) in patients with low, intermediate, and high surgical risk, as well as in patients with a failed aortic bioprosthetic valve. Current guidelines do not address the use of valve-in-valve (ViV) TAVR for management of PVE in patients who are at high risk for surgical intervention. The authors present a case of a patient with aortic valve PVE after surgical aortic valve replacement (SAVR); he was treated with valve-in-valve (ViV) TAVR due to the high surgical risk. The patient was discharged, but he returned to the hospital with PVE and valve dehiscence 14 months after ViV TAVR, after which he successfully underwent re-operative SAVR.</abstract><cop>United States</cop><pub>Cureus Inc</pub><pmid>37228546</pmid><doi>10.7759/cureus.38021</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2168-8184 |
| ispartof | Curēus (Palo Alto, CA), 2023-04, Vol.15 (4), p.e38021 |
| issn | 2168-8184 2168-8184 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10205151 |
| source | PubMed Central; PubMed Central Open Access |
| subjects | Anesthesiology Antibiotics Blood pressure Cardiac/Thoracic/Vascular Surgery Cardiology Edema Endocarditis Esophagus Fistula Heart failure Hypertension Kidney diseases Leukocytes Patients Prostheses Pulmonary embolisms Surgery Tomography Ultrasonic imaging |
| title | Surgical Aortic Valve Replacement to Treat Prosthetic Valve Endocarditis After Valve-in-Valve Transcatheter Aortic Valve Replacement |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T01%3A01%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Surgical%20Aortic%20Valve%20Replacement%20to%20Treat%20Prosthetic%20Valve%20Endocarditis%20After%20Valve-in-Valve%20Transcatheter%20Aortic%20Valve%20Replacement&rft.jtitle=Cur%C4%93us%20(Palo%20Alto,%20CA)&rft.au=Jena,%20Nihar&rft.date=2023-04-23&rft.volume=15&rft.issue=4&rft.spage=e38021&rft.pages=e38021-&rft.issn=2168-8184&rft.eissn=2168-8184&rft_id=info:doi/10.7759/cureus.38021&rft_dat=%3Cproquest_pubme%3E2821273405%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2821273405&rft_id=info:pmid/37228546&rfr_iscdi=true |